237 related articles for article (PubMed ID: 25301381)
1. Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.
Abad C; Cheung-Lau G; Coûté-Monvoisin AC; Waschek JA
Neuroimmunomodulation; 2015; 22(3):203-12. PubMed ID: 25301381
[TBL] [Abstract][Full Text] [Related]
2. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice.
Fukuda W; Takagi T; Katada K; Mizushima K; Okayama T; Yoshida N; Kamada K; Uchiyama K; Ishikawa T; Handa O; Konishi H; Yagi N; Ichikawa H; Yoshikawa T; Cepinskas G; Naito Y; Itoh Y
Dig Dis Sci; 2014 Jun; 59(6):1142-51. PubMed ID: 24442266
[TBL] [Abstract][Full Text] [Related]
5. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
6. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
[TBL] [Abstract][Full Text] [Related]
7. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.
Abad C; Tan YV; Cheung-Lau G; Nobuta H; Waschek JA
PLoS One; 2012; 7(5):e36922. PubMed ID: 22615845
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
9. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adeno-associated virus carrying thymosin β
Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
[TBL] [Abstract][Full Text] [Related]
12. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression.
Takagi T; Naito Y; Mizushima K; Akagiri S; Suzuki T; Hirata I; Omatsu T; Handa O; Kokura S; Ichikawa H; Yoshikawa T
Dig Dis Sci; 2010 Oct; 55(10):2797-804. PubMed ID: 20094779
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
15. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY 3-36 attenuates trinitrobenzene sulfonic acid-induced colitis in mice by modulating Th1/Th2 differentiation.
Li Z; Kuang X; Chen T; Shen T; Wu J
Bioengineered; 2022 Apr; 13(4):10144-10158. PubMed ID: 35443853
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
Shen C; Dillissen E; Kasran A; Lin Y; Clydesdale G; Sienaert I; Jonghe SD; Gao LJ; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
J Interferon Cytokine Res; 2006 Aug; 26(8):575-82. PubMed ID: 16881868
[TBL] [Abstract][Full Text] [Related]
18. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
19. Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.
Yang Y; Wang H; Dou Y; Wang Y; Han G; Wang R; Wang L; Guo R; Xiao H; Li X; Shen B; Shi Y; Chen G; Li Y
Clin Exp Immunol; 2011 Sep; 165(3):372-82. PubMed ID: 21668898
[TBL] [Abstract][Full Text] [Related]
20. Recovery from TNBS-induced colitis leads to the resistance to recurrent colitis and an increased ratio of FOXP3 to CD3 mRNA.
Chen DF; Lu LG; Tao KZ; Lu ZJ; Yuan YZ
J Dig Dis; 2013 Nov; 14(11):587-95. PubMed ID: 23786412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
